BCIM
AGN

British Columbia Investment Management’s Allergan Inc AGN Stock Holding History

British Columbia Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-366,887
Closed -$78M – 811
2014
Q4 		$78M Sell
366,887
-47,069
-11% -$9.36M 0.64% 29
2014
Q3 		$73.8M Buy
413,956
+1,612
+0.4% +$268K 0.62% 34
2014
Q2 		$69.8M Sell
412,344
-11,355
-3% -$1.77M 0.56% 41
2014
Q1 		$52.6M Sell
423,699
-31,989
-7% -$3.9M 0.44% 55
2013
Q4 		$50.6M Buy
455,688
+17,788
+4% +$1.7M 0.4% 58
2013
Q3 		$39.6M Buy
437,900
+35,383
+9% +$3.18M 0.33% 76
2013
Q2 		$33.9M Buy
+402,517
New +$41.8M 0.28% 89

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

British Columbia Investment Management's AGN Position: Q1 2015 in Review

British Columbia Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 366,887 shares — an estimated $78M sold.

British Columbia Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $78M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • British Columbia Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • British Columbia Investment Management sold 366,887 Allergan Inc shares in Q1 2015, an estimated $78M.
  • British Columbia Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • British Columbia Investment Management's Allergan Inc position peaked at $78M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on British Columbia Investment Management's 13F filing for Q1 2015, filed 5 May 2015.